throbber
Proc. Natl. Acad. Sci. USA
`Vol. 89, pp. 7022-7025, August 1992
`Biochemistry
`
`Evidence that MutY and MutM combine to prevent mutations by an
`oxidatively damaged form of guanine in DNA
`(8-oxo-7,8-dihydroguanlne/8-hydroxyguanine/DNA glycosylase/Fpg protein/mismatch repair)
`MARK LEO MICHAELS*, CHRISTINA CRUZ*, ARTHUR P. GROLLMANt, AND JEFFREY H. MILLER*t
`*Department of Microbiology and Molecular Genetics and the Molecular Biology Institute, University of California, Los Angeles, CA 90024; and tDepartment
`of Pharmacological Sciences, State University of New York, Stony Brook, NY 11794-8651
`Communicated by Charles Yanofsky, May 6, 1992 (received for review January 30, 1992)
`
`It has been previously shown both in vivo and
`ABSTRACT
`in vitro that DNA synthesis past an oxidatively damaged form
`of ganine, 7,8-dihydro-8-oxoguanine (8-oxoG), can result in
`the nusincorporation of adenine (A) opposite the 8-oxodG. In
`this study we show that MutY glycosylase is active on a
`site-specific, oxidatively damaged A/8-oxoG mispair and that
`it removes the undamaged adenine from this mispair. Strains
`that lack active MutY protein have elevated rates of G-C T-A
`transversions. We find that the mutator phenotype of a inut)
`strain can be fully complemented by overexpressing MutM
`protein (Fpg protein) from a plasmid clone. The MutM protein
`removes 8-oxoG lesions from DNA. In addition, we have
`isolated a strain with a chromosomal mutation that suppresses
`the mutY phenotype and found that this suppressor also
`overexpresses MutM. Finally, a mutY mutM double mutant has
`a 25- to 75-fold higher mutation rate than either mutator alone.
`The data strongly suggest that MutY is part of an intricate
`repair system directed against 8-oxoG lesions in nucleic acids
`and that the primary function of MutY in vivo is the removal
`of adenines that are misincorporated opposite 8-oxoG lesions
`during DNA synthesis.
`
`All organisms that use molecular oxygen need to defend
`themselves from the reactive byproducts of oxygen metab-
`olism. Reactive oxygen species such as superoxide, hydro-
`gen peroxide, and hydroxyl radical can be produced by the
`incomplete reduction of oxygen during aerobic metabolism
`(1). These oxidants can also be generated from lipid perox-
`idation, from phagocytic cells, and by exposure to radiation
`(1). Although organisms have developed systems to control
`active oxygen species, those that escape the primary de-
`fenses can damage nucleic acids and other cellular macro-
`molecules.
`Oxidative damage to DNA has been estimated at 104
`lesions per cell per day in humans and an order of magnitude
`higher in rodents (2). Not surprisingly, organisms have de-
`veloped a second line of defense to repair the oxidative
`damage to DNA. One of the lesions that is actively removed
`is 7,8-dihydro-8-oxoguanine (8-oxoG, also termed 8-hydroxy-
`guanine). The lesion is removed by the glycosylase/apurinic
`endonuclease activity of the MutM protein [Fpg protein or
`8-oxoG glycosylase] (3, 4). Recently, it has been shown that
`DNA synthesis past 8-oxoG can result in the misincorpora-
`tion of adenine opposite the damaged guanine (5-7) and that
`inactivation of the mutM (_fpg) gene leads specifically to G-C
`T-A transversions (4, 8).
`In this paper we present evidence that Escherichia coli has,
`at least in the case ofthe 8-oxoG lesion, a third line ofdefense
`against oxidative damage to DNA. Unlike the first two forms
`of protection, which target the active oxygen species or the
`damage it inflicts on nucleic acids, this activity leads to the
`
`correction of errors that are induced by replication of tem-
`plates containing 8-oxoG lesions. We find that MutY protein,
`originally identified as an adenine glycosylase active on A/G
`mispairs (9), can also remove the undamaged adenine from
`A/8-oxoG mispairs. Strains that lack active MutY protein
`have elevated rates of G-C -+ TEA transversions (10). Over-
`expressing the MutM protein from a plasmid clone can
`completely complement the mutator phenotype of a mutY
`strain. We have isolated a strain with a chromosomal muta-
`tion that suppresses mut Yand found that it has 15-fold greater
`MutM activity than the parental strain. Finally, a mutM mutY
`double mutant shows a 20-fold higher rate of G-C -* TEA
`transversions than the sum of G-C -* T-A transversions in
`either mutant alone. These observations suggest that the
`primary function of MutY glyrosylase in vivo is the removal
`of adenines that have been misincorporated opposite 8-oxoG
`lesions during DNA replication, and that MutY and MutM
`are part of a multiple line of defenses against oxidative
`damage to DNA.
`
`MATERIALS AND METHODS
`Ofigodeoxynucleotides. The 23-mer oligodeoxynucleotides,
`including the one containing the site-specific 8-oxoG lesion,
`were synthesized and purified as described (6, 11). The
`purified oligomers (4 pmol) were 32P-labeled at the 5' termi-
`nus with 10 units of T4 polynucleotide kinase in the presence
`of 7 pmol of [P32P] ATP (6 Ci/humol; New England Nuclear;
`1 Ci = 37 GBq) for 10 min at 370C. After heat inactivation at
`900C for 7 min, the labeled primers were annealed with an
`excess of unlabeled complementary oligodeoxynucleotide at
`900C in 50 mM NaCl for 2 min, cooled to room temperature,
`and then incubated on ice. The sequences of the oligodeox-
`ynucleotides are shown below (nucleotides involved in mi-
`spair formation are underlined; GO, 8-oxoG).
`(1) 5'-CTCTCCCTTCQQCTCCTllCCTCT-3'
`
`(2) 5'-CTCTCCCTTCGCTCCTTTCCTCT-3'
`
`(3) 5'-AGAGGAAAGGAGAGAAGGGAGAG-3'
`
`(4) 5'-AGAGGAAAGGAGCGAAGGGAGAG-3'
`MutY Glycosylase Assay. Glycosylase reactions were car-
`ried out in a solution (10 ILI) containing 20 mM Tris HCl (pH
`7.6), 0.5 pug of bovine serum albumin, 10 mM EDTA, 45 ng
`of MutY glycosylase [purified essentially as previously de-
`scribed (9)], and 20 fmol of 23-mer duplex with the indicated
`mispair. After incubation at 370C for 30 min, reactions were
`terminated by the addition of2 jul of 1 M NaOH and incubation
`
`The publication costs of this article were defrayed in part by page charge
`payment. This article must therefore be hereby marked "advertisement"
`in accordance with 18 U.S.C. §1734 solely to indicate this fact.
`
`Abbreviation: 8-oxoG, 7,8-dihydro-8-oxoguanine.
`tTo whom reprint requests should be addressed.
`
`7022
`
`GDX 1006
`
`

`

`Biochemistry: Michaels et al.
`at 900C for 4 min. This also served to cleave any apurinic/
`apyrimidinic sites generated by the glycosylase. Four micro-
`liters of loading dye (95% formamide/20 mM EDTA/0.05%
`bromophenol blue/0.05% xylene cylanol FF) was added to the
`mix and aliquots were run in denaturing (7 M urea) 15%
`polyacrylamide gels.
`Strains and Plasmids. E. coli strain GT100 is ara, A(gpt-
`lac)S, rpsL, [F'1acIqL8, proA+B+]. Strain CC104 is ara,
`A(gpt-4ac)S, [F'lacI378, lacZ461, proA+B+] (12). CSH115 is
`ara, A(gpt-lac)5, rpsL, mutS::mini-TnlO and CSH116 is ara,
`A(gpt-4ac)5, rpsL, mutDS zaeSO2::TnlO; these strains are
`further described by Miller (13). Plasmid pKK223-3 was
`purchased from Pharmacia, and pKK-Fapy2 carries a wild-
`type mutM (fpg) gene (4). All media and genetic manipula-
`tions, unless otherwise stated, were as described (14).
`Complementation Tests. Eight independent cultures con-
`taining plasmid pKK223-3 or pKK-Fapy2 in strains GT100,
`GT100 mutY::mini-TnJO, GT100 mutM, or GT100
`mutS::mini-TnJO were grown overnight in LB medium sup-
`plemented with ampicillin (100lg/ml), and 50-,lI samples
`were plated onto LB with rifampicin (200 ,g/ml). After
`overnight incubation at 37°C, Rifr colonies were counted.
`MutM Protein Assay. Crude extracts were obtained by
`growing Supl7 [a strain carrying a suppressor of mutY(C.C.,
`M.L.M., and J.H.M., unpublished work)] in LB medium.
`Cells (30 OD6co
`units) were collected by centrifugation,
`resuspended in 2 ml 50 mM Tris HCl, pH 7.5/20 mM f3-mer-
`captoethanol/1 mM phenylmethylsulfonyl fluoride, and fro-
`zen at -70°C. The solution was thawed and sonicated on a
`Fisher Sonic Dismembrator model 300 on maximum output
`for two 30-sec bursts. The cell debris was removed by
`centrifugation (27,000 x g) for 20 min at 4°C. The supernatant
`was taken and glycerol was added to a concentration of 5%
`(vol/vol). The protein content of the extracts was measured
`with the BioRad protein assay kit using bovine serum albu-
`min as the standard. Various amounts of extract were incu-
`bated with 20 fmol of 23-mer duplex containing a C/8-oxoG
`pair with a 32p label in the 8-oxoG-containing strand (oligo-
`nucleotides 4 and 1; see above). The reaction was incubated
`at 37°C for 30 min in 10 ,ul of 20 mM Tris-HCl, pH 7.6/10 mM
`EDTA containing bovine serum albumin at 50 ,g/ml. The
`reaction was stopped by the addition of 3 1l of loading dye
`and by heating at 1000C for 2 min. An aliquot of the reaction
`was loaded onto a denaturing 15% polyacrylamide gel. Au-
`toradiographs were quantitated by measuring transmittance
`of substrate and product bands with a Bio-Rad 620 video
`densitometer.
`Mutational Specificity Tests. Four or more independent
`cultures of CC104 and its derivatives were grown overnight,
`and 50 IlI was plated onto LB with rifampicin (100 ,ug/ml) and
`100 1l onto minimal lactose medium. After overnight incu-
`bation at 37°C, Rifr colonies were counted. Lac+ colonies
`were counted after 2 days of incubation at 37°C. For the
`double mutant (mutYmutM), 10-2 dilutions were done before
`plating. Lac+ colonies were somewhat difficult to count for
`the double mutant due to Lac+ colonies arising on the plate
`during incubation. Incubation times were reduced to combat
`this problem. This problem does not occur with the Rifr
`mutants.
`
`RESULTS
`MutY Glycosylase Activity on A/8-oxoG Mispairs. Du-
`plexes (23-mers) containing an undamaged A/G mispair or a
`site-specific A/8-oxoG mispair were tested as substrates for
`MutY glycosylase. The glycosylase was active on the duplex
`containing the A/8-oxoG mispair and removed the undam-
`aged adenine from the duplex (Fig. 1, lane 7). MutY acted
`strictly as a glycosylase in this reaction-no endonuclease
`activity was detected. As previously observed (9), MutY was
`
`Proc. Natl. Acad. Sci. USA 89 (1992)
`
`7023
`
`-MutY
`+MutY
`Mispair Ai Ab* 1GO bo A A* A;0A/o*
`2
`3
`4
`5
`6
`8
`7
`1
`10
`40
`
`m
`
`Substrates
`
`Products
`
`40
`
`4w
`
`Activity of MutY glycosylase on mispairs containing a
`FIG. 1.
`site-specific 8-oxoG lesion. Glycosylase reactions were carried out
`as described in Materials and Methods. Blank reaction mixtures
`(lanes 1-4) contained everything except the glycosylase. Reactions
`were terminated by the addition of 2 ,ul of 1 M NaOH and incubation
`at 90°C for 4 min. This also served to cleave any apuninic sites
`generated by the glycosylase. The progress of the glycosylase
`reaction can therefore be monitored by a change in migration of the
`cleaved products. The A oligomer is sequence no. 3 (see Materials
`and Methods); the G and GO (8-oxoG) oligomers are nos. 2 and 1,
`respectively. The star indicates which strand in the duplex is
`32P-labeled.
`
`also active on the undamaged adenine of an A/G mispair and
`did not cause strand cleavage at the apurinic site (lane 5).
`All of the other possible combinations of mispairs with
`8-oxoG were tested as potential substrates for MutY glyco-
`sylase. MutY does not removecytosine, guanine, or thymine
`opposite 8-oxoG, nor does it remove 8-oxoG from any of the
`damaged duplexes (data not shown). MutY was active only
`on the A/8-oxoG and A/G mispairs.
`The relative activity of MutY glycosylase on an A/8-oxoG
`or A/G mispair duplex substrate was determined. MutY
`removed the undamaged adenine from the A/G and A/8-
`oxoG mispairs at approximately the same rate (Fig. 2). The
`glycosylase specific activity on these substrates was >26
`nmol/hr per mg of protein. This is comparable to the glyc-
`osylase specific activity observed for purified MutY glyco-
`sylase on a phage fl-derived heteroduplex containing an A/G
`mispair (1.35 nmol/hr per mg; ref. 9).
`Complementation Tests. Previous work has shown that
`mutY (10) and mutM (fpg) (8) have nearly identical mutation
`spectra in vivo and that both specifically increase G-C -- T-A
`transversions. Therefore, we suspected that the two proteins
`could be part of a common repair pathway. The above
`biochemical assay suggested that 8-oxoG might be common
`to both repair proteins. In the proposed scheme, the MutM
`protein would remove 8-oxoG lesions in DNA, and MutY
`A*/GO
`Mispair
`5.0 1.0 0.5 0.1'
`MutY (ng)
`8
`9
`6
`7
`
`A*/G
`5.0 1.0 0.5 0.1'
`2
`3
`4
`5
`
`0
`1
`*M'
`
`Substrates
`
`Products
`
`4* _ sQr_
`iw. now ki_. 4m
`
`Relative activity of MutY glycosylase on A/G and
`FIG. 2.
`A/8-oxoG substrates. The blank reaction (lane 1) and glycosylase
`reactions (lanes 2-9) were performed on duplex 23-mers containing
`the indicated mismatch and analyzed as described in the legend to
`Fig. 1 except that the amount of MutY glycosylase was varied as
`shown in the figure. The A* oligomer in each duplex is no. 3
`(Materials and Methods); the G and GO (8-oxoG) oligomers are nos.
`2 and 1, respectively. The blank reaction (no glycosylase) was
`performed on A*/G.
`
`GDX 1006
`
`

`

`7024
`
`Biochemistry: Michaels et al.
`
`Complementation of a mutY strain with a
`Table 1.
`MutM-overproducing plasmid
`
`No. of Rifr colonies per 108
`cells
`
`Strain
`
`pKK-Fapy2
`pKK223-3
`1±1
`it 1
`GT100
`57 ± 13
`GT100 mutY:: mini-Tn)O
`2 + 1
`1± 1
`13 ± 5
`GT100 mutM
`102 ± 21
`71 ± 18
`GT100 mutS:: mini-TnIO
`Eight independent cultures were grown to saturation and plated
`onto LB medium with rifampicin. The average number of Rifr
`colonies (±SD) per 108 cells is reported. Plasmid pKK223-3 is the
`vector and pKK-Fapy2 is a MutM overproducer (4).
`glycosylase would remove any adenines that were misincor-
`porated opposite 8-oxoG lesions that were not removed
`before replication.
`The results of complementation tests support this theory.
`By overexpression of MutM protein in a mutY strain, the
`mutation rate of mutY was reduced to wild-type levels (Table
`1). Overexpression of MutM protein in a mismatch repair-
`deficient strain (mutS) had no effect on its mutation rate. This
`control shows that the overproducer does not affect a mu-
`tator strain that causes mutations by an unrelated pathway.
`As expected, the clone complemented a mutM strain, and the
`vector alone had no effect on the mutation rate of any strain.
`mutY Double Mutant. Consis-
`Characterization of a mut
`tent with the idea that MutY glycosylase and the MutM
`protein protect the cell from the potentially mutagenic
`8-oxoG lesion, a strain that lacks both defense systems has an
`extremely high rate of GC -- TA transversions. We used P1
`phage to transfer a mutY::mini-TnlO marker into a mutM
`strain and found that, like mutM and mutY, the double mutant
`was very specific for stimulating G-C -- T-A transversions
`(Table 2). However, the mutation rate of the double mutant,
`as judged by both the generation of Rifr colonies and the rate
`of GC -. T-A transversions in a Lac+ reversion assay, is
`20-fold higher than the sum of the separate mutators, sug-
`gesting that they are involved in a related repair system
`(Table 3).
`The importance of the repair system is illustrated by
`comparing the mutation rate of a mutM mutY double mutant
`to the mutation rates obtained when other well-characterized
`error-avoidance systems are disabled. Strains lacking the
`polymerase III editing subunit (mutD) or the methyl-directed
`mismatch repair system (mutS) are the most potent mutator
`strains in E. coli. Asjudged by the formation ofRifr colonies,
`the mutM mut Y double mutant is just as strong a mutator as
`mutD and about an order of magnitude stronger than a strain
`lacking the mismatch repair system (Table 3).
`Characterization of a Suppressor of mutY. We have char-
`acterized a suppressor of mutYthat maps near to but distinct
`Mutational specificity of mutM mutY strains
`Table 2.
`No. of
`No. of
`Lac+
`Lac+
`Reversion
`revertants
`Strain
`Strain
`revertants
`event
`CC101 mutM mutY
`GCG CC101
`1
`1
`A-T
`G-C -AT CC102
`2
`CC102 mutM mutY
`2
`GCO CC103
`<1
`CC103 mutM mutY
`<1
`G-C
`5300
`CC104 mutM mutY
`G-C TA CC104
`2
`1
`1
`CC105 mutM mutY
`A-T -- T-A CC105
`A-T -. GC CC106
`3
`CC106 mutM mutY
`<1
`Four or more independent cultures of each strain were grown to
`saturation in LB medium and plated onto minimal lactose medium.
`Average number of Lac+ colonies per 108 cells is recorded above.
`Strains in this table are streptomycin-resistant (rpsL) versions of the
`CC101-106 series (12).
`
`Proc. NatL Acad Sci. USA 89 (1992)
`
`Mutation frequency of mutM, mutY, and mutM
`Table 3.
`mutY strains
`
`Strain
`
`No. of Rifr
`No. of Lac+
`colonies
`revertants
`5-10
`3
`CC104
`151
`25
`CC104 mutM
`290
`62
`CC104 mutY
`8200
`1900
`CC104 mutM mutY
`760
`ND
`CSH115 (mutS)
`4900
`ND
`CSH116 (mutD)
`Mutation frequency of the double mutant is compared with those
`of the separate mutM and mutY mutants as well as with the mutation
`frequency of strains lacking the polymerase III editing function
`(mutD) or the mismatch repair system (mutS). Cultures were grown
`to saturation in LB medium and plated onto minimal lactose medium
`and LB with rifampicin. Average numbers of Lac+ and Rjfr colonies
`per 108 cells are recorded. ND, not determined.
`from the mutM gene (C.C., M.L.M., and J.H.M., unpub-
`lished work). We suspected that this antimutator candidate,
`Supl7, might overexpress MutM protein based upon our
`previous complementation results. In fact, when the extracts
`were tested for glycosylase/apurinic endonuclease activity
`on a 23-mer duplex containing a site-specific C/8-oxoG pair,
`the Supl7 extract had 15-fold greater activity than the parent
`strain. These results will be described in detail elsewhere.
`
`DISCUSSION
`The attack of reactive oxygen species on DNA poses a
`substantial threat to the cell. Endogenous oxidants generated
`by the incomplete reduction of oxygen or by lipid peroxida-
`tion can damage DNA and may be a major cause of the
`physiological changes associated with aging and cancer (2).
`One of the products of oxidative attack on DNA is the
`8-oxoG lesion. It has been determined that rat liver cells have
`a steady-state level of over 4 x 105 8-oxoG lesions per cell,
`yet it is estimated that 8-oxoG lesions may represent only 5%
`of the total oxidative damage to DNA (2). Even more
`significant is the finding that 8-oxoG lesions can lead to
`replication errors. In vivo and in vitro studies have shown that
`adenine is frequently misincorporated opposite oxidatively
`damaged guanine residues in DNA (5-7). In a mutM strain the
`protein that removes 8-oxoG lesions in DNA is not active (3,
`4). The elevated level of G-C -- TA transversions in a mutM
`strain is thus due to the misinsertion of adenine residues
`opposite the accumulated 8-oxoG lesions in the parental
`strand during DNA replication. MutM (Fpg protein) can also
`excise formamidopyrimidine lesions in DNA (20).
`The 8-oxoG lesion is not only present in chromosomal
`DNA but is also found in the nucleotide pool as 8-oxo-dGTP.
`This damaged nucleotide is potentially mutagenic, as 8-oxo-
`dGTP can be frequently misincorporated opposite template
`adenines (15). The MutT protein hydrolyzes 8-oxo-dGTP to
`8-oxo-dGMP, thus eliminating the mutagenic substrate from
`the nucleotide pool (15). A strain that lacks active MutT
`C-G transversions (16).
`protein has elevated levels of A-T
`These transversions are presumably due to the misincorpo-
`ration of 8-oxo-dGTP opposite template adenines. Strains
`deficient in MutM or MutT protein have increased frequen-
`cies of opposite transversions. In a mutM strain, 8-oxoG
`lesions accumulate in the chromosome and lead to the
`misincorporation of adenine opposite template 8-oxoG le-
`sions and produce G-C -) TA transversions, while in a mutT
`strain 8-oxo-dGTP nucleotides are misinserted opposite tem-
`plate adenines, resulting in A-T -+ CG transversions.
`Cells have multiple lines of defense against oxidative
`damage to DNA. The primary line of defense guards against
`the active oxygen species themselves. Oxidants can be
`
`GDX 1006
`
`

`

`Biochemistry: Michaels et al.
`
`O
`
`H
`
`NH2
`
`dR
`
`B r,^,
`
`+ Oxidative Stress
`1 1X 1 11
`r I
`I
`G111GIII
`Replicatio
`
`MUMGO
`
`I
`
`XI
`
`I
`
`I
`
`1,I
`
`I
`
`1
`
`1
`
`1
`
`1
`
`utY
`
`I
`
`I I~I
`
`I
`Repair
`
`I
`
`\
`
`~~~II IG01 I
`Repair
`
`I
`
`,I
`
`I
`
`I D
`
`Role of MutM and MutY in the 8-oxoG repair system. (A)
`FIG. 3.
`Structure of the predominant tautomeric form of the 8-oxoG lesion.
`dR, deoxyribose. (B) Oxidative processes can lead to 8-oxoG lesions
`in DNA. The MutM protein removes 8-oxoG lesions and subsequent
`repair restores the original G-C base pair. If the 8-oxoG lesion (GO)
`is not removed before replication, translesion synthesis can be
`accurate or inaccurate. Accurate translesion synthesis results in a
`C-8-oxoG pair-a substrate for the MutM protein. However, inac-
`curate translesion synthesis leads to the misincorporation of dAMP
`opposite the 8-oxoG lesion (5-7). MutY glycosylase removes the
`misincorporated dA from the A/8-oxoG mispairs that result from
`error-prone replication past the 8-oxoG lesion. Repair polymerases
`are less error-prone during translesion synthesis (5) and can lead to
`a C-8-oxoG pair-a substrate for MutM.
`
`eliminated by various enzymatic and nonenzymatic systems
`such as superoxide dismutase, catalase, ascorbic acid, and
`j-carotene (17). However, active oxygen species that escape
`these primary defenses can damage nucleic acids and other
`cellular macromolecules. The second line ofdefense works to
`remove the oxidative damage from nucleic acids. The MutM
`and MutT proteins are examples of this type of defense.
`Exonuclease III, endonuclease IV, and the excision nuclease
`and exonuclease activities associated with UvrAB are further
`examples of enzymes that can repair oxidized DNA (18-20).
`The MutY protein represents a third level of protection
`against oxidative damage to DNA. Unlike the other defenses,
`which seek to neutralize the reactive oxygen species or repair
`the damage those species cause to nucleic acids, MutY
`glycosylase helps to correct the errors that result from the
`replication of DNA containing oxidative damage. It removes
`undamaged adenines that are misincorporated opposite tem-
`plate 8-oxoG lesions in DNA.
`Although MutY glycosylase can remove the undamaged A
`from both an A/8-oxoG mispair or an undamaged A/G
`mispair duplex in DNA (Fig. 1), our results suggest that its
`primary function in vivo is the removal of the A from the
`oxidatively damaged mispair, A/8-oxoG. First, overexpres-
`sion of MutM protein, which removes 8-oxoG lesions, com-
`pletely complements a mutY strain (Table 1). Similarly, a
`
`Proc. Natl. Acad. Sci. USA 89 (1992)
`
`7025
`
`chromosomal suppressor of the mutator phenotype of mutY
`had 15-fold greater glycosylase/apurinic endonuclease activ-
`ity on an 8-oxoG substrate than the parent strain. Finally, a
`mutM mutYdouble mutant has an extremely high G-C -- T-A
`mutation rate (Tables 2 and 3). The mutation rate is about
`20-fold higher than would be expected if the genes were
`involved in unrelated repair mechanisms. In fact, the muta-
`tion rate of the double mutant suggests that although the only
`mutagenic substrate this system handles is 8-oxoG, it is
`nonetheless one of the more important error-avoidance sys-
`tems in E. coli.
`The A/8-oxoG mispair represents an oxidatively damaged
`purine/purine mispair that is not efficiently removed by the
`proofreading function of polymerase III and appears to
`require a devoted repair system to prevent the oxidatively
`damaged guanine from introducing mutations into the chro-
`mosome. An intricate mechanism involving the MutM,
`MutT, and MutY proteins has evolved to protect the cell from
`the mutagenic effect of 8-oxoG (see Fig. 3).
`
`We thank V. Bodepudi and R. Rieger for preparing the oligonu-
`cleotides containing the 8-oxoG lesion. We thank J. Tchou for helpful
`discussions and H. Hsiao for technical assistance. This work was
`supported by Grant GM32184 from the National Institutes of Health
`to J.H.M., Grant CA47995 from the National Cancer Institute to
`A.P.G., and a California Institute for Cancer Research Fellowship to
`M.L.M.
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`Halliwell, B. & Gutteridge, J. M. C. (1989) Free Radicals in
`Biology and Medicine (Clarendon, Oxford), 2nd Ed.
`Fraga, C. G., Shigenaga, M. K., Park, J.-W., Degan, P. &
`Ames, B. N. (1990) Proc. Nati. Acad. Sci. USA 87,4533-4537.
`Tchou, J., Kasai, H., Shibutani, S., Chung, M.-H., Grollman,
`A. P. & Nishimura, S. (1991) Proc. Natl. Acad. Sci. USA 88,
`4690-4694.
`Michaels, M. L., Pham, L., Cruz, C. & Miller, J. H. (1991)
`Nucleic Acids Res. 19, 3629-3632.
`Shibutani, S., Takeshita, M. & Grollman, A. P. (1991) Nature
`(London) 349, 431-434.
`Moriya, M., Ou, C., Bodepudi, V., Johnson, F., Takeshita, M.
`& Grollman, A. P. (1991) Mutat. Res. 254, 281-288.
`7. Wood, M. L., Dizdaroglu, M., Gajewski, E. & Essigman, J. M.
`(1990) Biochemistry 29, 7024-7032.
`Cabrera, M., Nghiem, Y. & Miller, J. H. (1988) J. Bacteriol.
`170, 5405-5407.
`Au, K. G., Clark, S., Miller, J. H. & Modrich, P. (1989) Proc.
`Natl. Acad. Sci. USA 86, 8877-8881.
`Nghiem, Y., Cabrera, M., Cupples, C. G. & Miller, J. H. (1988)
`Proc. Natl. Acad. Sci. USA 85, 2709-2713.
`Bodepudi, V., Iden, C. R. & Johnson, F. (1991) Nucleotides
`Nucleosides 10, 755-761.
`Cupples, C. G. & Miller, J. H. (1989) Proc. Natl. Acad. Sci.
`USA 86, 5345-5349.
`Miller, J. H. (1992) A Short Course in Bacterial Genetics (Cold
`Spring Harbor Lab., Cold Spring Harbor, NY).
`Miller, J. H. (1972) Experiments in Molecular Genetics (Cold
`Spring Harbor Lab., Cold Spring Harbor, NY).
`Maki, H. & Sekiguchi, M. (1992) Nature (London) 355, 273-
`275.
`Yanofsky, C., Cox, E. C. & Horn, V. (1966) Proc. Natl. Acad.
`Sci. USA 55, 274-281.
`Degan, P., Shigenaga, M. K., Park, E.-M., Alperin, P. E. &
`Ames, B. N. (1991) Carcinogenesis 12, 865-871.
`Demple, B., Johnson, A. & Fung, D. (1986) Proc. Natl. Acad.
`Sci. USA 83, 7731-7735.
`Lin, J. J. & Sancar, A. (1989) Biochemistry 28, 7979-7984.
`Czeczot, H., Tudek, B., Lambert, B., Laval, J. & Boiteux, S.
`(1991) J. Bacteriol. 173, 3419-3424.
`
`8.
`
`9.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`20.
`
`GDX 1006
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket